Puro New Zealand Limited - Wholesale
By Puro New Zealand
PledgeMe.Investment
Product,
NZ $1,620,000 pledged
17 people pledged
Closed
NZ $0 minimum target
This campaign hit its maximum target on 04/12/2019 at 4:55 PM and is now closed.
Make a PledgeAbout
Puro New Zealand Limited - Wholesale
Puro's equity crowdfunding and wholesale campaigns are now fully subscribed. To be on the waiting list and be kept in the loop on possible future capital raising, please register your interest by clicking here.
The information below relates to Puro's Wholesale campaign - please refer to IM for explainer, and in footer of this campaign page for definition of wholesale investor.
Puro is setting out to become New Zealand’s best cultivator of medical cannabis and hemp.
We have secured two premium growing sites in sunny Marlborough and have formed a world-class team of experts to drive us forward.
We are the first medical cannabis company in New Zealand to have an approved cannabis licence prior to conducting a PledgeMe crowdfunding campaign, and already have purchase agreements with seven pharmaceutical manufacturers and wholesalers.
With land secured, a licence in place and letters of intent signed with large buyers, there’s only one thing we need to get growing: You.
We invite you to join us on our journey now. An investment with us positions you for considerable growth in this exciting industry. With Puro, you’ll be at the forefront of pioneering new medicine.
Offer at a glance
Puro is undertaking an equity crowdfunding campaign to raise $2million from New Zealand residents. Concurrently, a wholesale campaign is also being undertaken to raise a further $2million from wholesale investors. Shares are priced at $1 each for both offers.
- The crowdfunding offer equates to 7.29% of the investor shares available. The minimum investment amount is $500.
- The wholesale offer is separate to the crowdfunding offer and is also for a 7.29% stake in Puro New Zealand Limited. The minimum investment amount is $50,000.
Our land
Puro has secured two premium growing sites in Marlborough. These sites provide us with the capacity to be the largest cultivator in New Zealand.
We handpicked our sites due to their high sunshine hours, intense UV ratings, and its clean environment. Couple that together with rich soils and a unique micro-climate give us the perfect locations.
Marlborough already produces some of the world’s premium food and wine, our product will be equally world-class.
Destined to become Puro's research headquarters, this 9-hectare property is currently part of an existing cherry orchard nestled in a quiet area of the Waihopai Valley in Marlborough. We plan to build high-security greenhouses for growing medical cannabis and establish research facilities in existing buildings.
This will enable us to produce premium indoor cannabis — a product that we anticipate will be among the best in the world.
We expect to grow up to 200 plants in our secure facility at Waihopai, and undertake research on all strains and cultivars including high-THC genetics
- Optional expansion: 33.5 ha
- Site crop: Premium medicinal cannabis
- Facilities: 400m2 research facility with three vegetative growing room and commerical greenhouses covering 10,000-30,000m2
- Potential output: 20,000—60,000 kg dried flower PA
- Lease duration: 21 years plus right to purchase
Our research has shown this coastal site is high in sunshine hours and receives a gentle salt spray from the ocean, which our botanists say will ward off pests naturally, and improve plant health. This natural self-defence has another benefit: it will also increase the cannabinoid profile of our plants. This should translate into higher yields, which makes for greater returns for our investors.
- Optional expansion: 80 ha
- Site crop: Low THC hemp
- Potential output: 40,000—160,000 kg dried hemp flower PA
- Lease duration: 20 years
Licenced to grow
Under current New Zealand law, growing, extracting, and manufacturing cannabis for therapeutic use can only be undertaken for scientific research. This will change soon with the introduction of the Medicinal Cannabis Scheme, which we expect will be operational in March 2020.
Puro is the first medical cannabis company in New Zealand with an approved licence to undertake scientific cannabis research prior to commencing a crowdfunding campaign.
We currently have our licence pending with the Ministry of Health to cultivate low-THC hemp at Kekerengu, and we anticipate this to be granted in advance of our planned planting in December 2019.
A rapidly growing market
The global medical cannabis market is big and getting bigger. With governments around the world increasing access for those with chronic health conditions, it’s one of the fastest-growing industries in the world.
While it is clear that the global medical cannabis market is increasing, estimates of the exact size of the international medical cannabis market vary greatly.
For example:
- “The global medical cannabis market size was estimated to reach a value of US$13.4billion in 2018. The market is further expected to reach a value of US$44.4billion by 2024.”
- “Medical Marijuana Market size is set to exceed US$55.0 billion by 2024.”
- The global legal marijuana market is expected to reach USD$146.4 billion by the end of 2025.”
- “Barclays suggests that the global cannabis market could be worth USD$272 billion by 2028.”
Closer to home, research from The AgriBusiness Group into the New Zealand market concluded that if 1% of those who could benefit from medical cannabis in New Zealand obtained a prescription, the market could be worth $379 million each year.
Valuation, growth plans and revenue
Given the rapidly growing nature of the medical cannabis market, it is not surprising there is potential for significant investor returns.
Puro has been conservatively valued at $25million, using an EBITDA multiplier of just 2 and an implied revenue multiplier of only 1.1. If the average Canadian multipliers (revenue multiplier of 4.8 and EBITDA multiplier of 15.9) were used to value Puro it would result in valuations between $98.9 million - $199.4 million, demonstrating the potential significant upside for investors.
Based on conservative profitability assumptions, we anticipate PledgeMe investors can expect an after-tax return on investment of 34% at the end of our first full year of production (at March 2021), and 66% by March 2022.
Use of Capital
Funds raised through our PledgeMe campaign will be primarily used to:
- Build our research facility
- Invest in security
- Purchase extraction equipment
- Greenhouse development
- Expand further into international market
- Adminstration and capital raising costs
Capitalisation Table
Shareholding details for pre- and post-offer shall be as follows:
About our Team
Puro was setup in 2018 by passionate South Islanders and since then we have formed a formidable team with considerable business, finance and cultivation expertise.
Tim Aldridge (managing director): Tim was born and raised in Blenheim and worked in business consultancy before setting up Party Warehouse in 2001, which he grew to become the South Island’s largest marquee and event company. HireKING was Tim’s next success, and in 2017 it was named as one of the top 50 fastest growing companies in New Zealand. Tim was also a founding director of Team Event, which runs some of the largest annual events in the South Island including the Great Kiwi Beer Festival and Electric Avenue. |
||
Sank Macfarlane (Director): A 5th generation Marlbourian, Sank’s family have farmed the Winterhome Farm, at Kekerengu on the Kaikoura Coast, for 130 years. Prior to his current role, Sank enjoyed a 16-year career in international banking, which provided him with a deep understanding of global financial markets. Sank is also a board member of the Marlborough Kaikoura Trail Trust which is funding, designing and building a cycleway from Picton to Christchurch.
|
||
Wayne Bailey (director): With more than 40 years’ experience as a chartered accountant, Wayne is the Executive Director of financial consultancy Taurus Group. He is a specialist in corporate restructuring, financial and succession planning as well as developing, growing and advising businesses. Wayne is an astute businessman, a clear thinker and a smart communicator. |
||
Tom Forrest (cultivation director, agronomist): An Australian 2018 Churchill Fellow, author of ‘A Global Analysis of Cannabis Cultivation’, and a leading consultant in the global cannabis space, Tom is leading Puro’s agronomic team to produce quality high-yielding cannabis and hemp at scale. Tom, who is co-founder of Indicated Technology, has also been instrumental in connecting Puro with pharmaceutical manufacturers and international buyers. |
Puro is surrounded by a talented team with proven track records across a range of sectors – from start-ups, investment and investor relations to governance, finance, horticulture and farming. Add to this the expertise of our internationally respected botany, agronomy and research partners, and you’ll see Puro is perfectly positioned for success.
Puro has partnered with the leading experts and brightest lights in the medical cannabis industry.
By aligning ourselves with the best in the world, we aim to generate the highest yields whilst reducing our costs of production. Ultimately, this will help us to increase profits and provide optimum returns for our shareholders.
Puro's achievements and what lies ahead
Our financial modelling will to take advantage of lucrative short-term pricing, which will put Puro into a cashflow positive position once our commercial facilities are built and operational (commencing mid-2020). This cashflow could be used to pay a dividend to all shareholders including, of course, our PledgeMe investors, although our anticipation is to use all surplus cash to expand and bolster our commercial facilities in order to scale quickly and enter global markets. We believe that reinvesting any dividends will leverage our growth and strengthen the company.
Any dividend payments made will be distributed equitably to shareholders, including, of course, our PledgeMe and Wholesale investors. Likewise, any increase in company value as we move into commercial cultivation and expand globally will be reflected in the value of your shareholding.
The directors have not outlined any exit strategy and nor can we make any promises around our intentions or possible directions in this space. Saying that, if Puro can achieve its plans of producing the “Sauvignon Blanc of Cannabis” becoming a NZ’s best and potentially biggest cultivator, with a global brand recognised for its quality, trust and consistency, our company could possibly become appealing to a larger buyer. This may potentially include another company wanting to enter the market or to leverage our branding and success into their existing operations and distribution channels.
The directors are unlikely to list Puro on the NZ or Australian stock exchanges (NZX or ASX).
Risks and mitigation
Note from PledgeMe
We have completed a Veda check on the company and their Director, as well as a Google check. There were no adverse findings.
The Directors's have all passed Police vetting and responsible person's tests as part of the cannabis research license approval.
Definition of wholesale investor
A wholesale investor can be defined as people who meets any one of these 5 criterion:
- are an investment business, in that their principal business involves investing in financial products, acting as an underwriter, providing financial advisory services, providing broking services or trading financial products;
- have, during the previous two year period, owned a portfolio of, or carried out transactions to acquire financial products of a value of at least $1 million;
- have, in the previous two years, materially participated in the investment decisions made by an investment business;
- have, or any entities controlled by them, have, as at the last day of the two most recently completed financial years, net assets or total consolidated turnover exceeding $5 million;
- are "eligible investors", and have certified that they have previous experience in acquiring or disposing of financial products that allows them to assess:
- the merits of the transaction;
- their own information needs in relation to the transaction;
- the adequacy of the information provided, that they understand the consequences of so certifying, and the grounds for this certification; or
- an authorised financial adviser, a chartered accountant, or a lawyer signs a written confirmation of the certification.
Updates 2
We did it - $4million raised!
06/12/2019 at 11:09 AM
THANKS!
In four weeks we’ve gone from being an unknown start-up to raising $4 million on PledgeMe - the highest ever equity crowdfunding campaign in New Zealand and Australia.
And today we are planting!
And we have you to thank for it – thank you for believing in us.
We’ve raised $2million in our equity campaign and $2million in our wholesale campaign, and we will use the money to build medical cannabis growing facilities and buy state-of-the-art processing equipment.
Nearly 750 people have backed us and there’s already 135 people on our waiting list for future investment opportunities (people can sign up here https://www.puro.co.nz/invest/).
Once again thank you so much for your support. It’s been incredibly humbling.
We have the land, we have the team, we have the licences and the buyers. And now, thanks to you, we have the capital we need to get growing.
Let’s do this!
The Puro team
Tim, Sank, Wayne and Tom
You need to pledge to see this update.
Details
Offer Details
Current Valuation | 23,417,862 |
Raise Minimum | 0 |
Raise Maximum | 2,000,000 |
Share Price | 1.00 |
Minimum Pledge | 50,000.00 |
Maximum Shares Offered | 2,000,000 |
Explanation of valuation:
An independent valuation of Puro New Zealand Ltd by Taurus Group has valued the company shares at $23,417,862. This has been determined by using a forecasted equity value analysis using an EBITDA (Earnings Before Interest, Tax, Depreciation & Amortisation) multiple of 2 for the 2021 year and accumulated losses from the initial 2020 year.
Another common method to value a company, particularly for crowdfunding in New Zealand, is to use a revenue multiplier (4-5 times revenue is often adopted). International benchmark data for the cannabis industry has determined multiples of 0.9 to 10.5, with an average of 4.8.
Applying a conservative multiplier of 1-2 times to forecast 2021 revenue would result in a valuation of Puro shares of between $20.6million – $41.2million. If the average multiple of 4.8 was applied, the valuation of Puro would lift to $98.9million, demonstrating the potential upside to investors.
The Directors have valued the total shares pre-raise at $23,417,862 in accordance with our independent valuation. Post-raise, if both our crowdfunding and wholesale offers are fully subscribed the valuation for Puro will be $29,347,845. We believe this provides excellent potential returns for our shareholders with forecasted return on investment on the above valuation being 34% (after tax) for the first full year trading 2021.
Financial Summary
Prev Year | Current Year | Est. FY 2025 | Est. FY 2026 | |
---|---|---|---|---|
Revenue | NZ $0 | NZ $172,080 | NZ $20,596,560 | NZ $37,585,200 |
Operating Expenses | NZ $0 | NZ $1,713,672 | NZ $6,857,624 | NZ $11,149,009 |
EBITDA | NZ $0 | -NZ $1,596,592 | NZ $13,305,523 | NZ $25,363,818 |
Net Profit | NZ $0 | -NZ $1,703,354 | NZ $12,267,735 | NZ $24,047,187 |
Company Details
Company Name: Puro New Zealand Ltd
Company Number: 7148653
Company Documents
Director Details
Name | Role | Profile URL | Invested? |
---|---|---|---|
Timothy James ALDRIDGE | Managing Director | https://www.linkedin.com/in/tim-aldridge-080586179/ | ✔ |
Sandford Samuel MACFARLANE | Director | https://www.linkedin.com/in/sank-macfarlane-14747674/ | ✔ |
Errol Wayne BAILEY | Director | https://www.linkedin.com/in/wayne-bailey-15994710/ | ✗ |
Questions 1
Hi Tim, you have mentioned future capital raising,will this be done in a pledge me setting and the shares you will be offering come from the current share holders stakes or do you intend to down water down the investors share as well who have purchased shares in this pledge me campaign as well ? cheers
Posted on 29-11-2019 by seanHi sean. The exact details of any future capital raising have not yet been determined. Whatever decisions are made will be informed by what is in the best interests of our shareholders.
Answered on 03-12-2019 by Puro New Zealand
Pledgers 17
04/12/2019 at 11:01am
"Faith, Trust and Angle Dust"
04/12/2019 at 5:24am
03/12/2019 at 11:16am
03/12/2019 at 10:18am
02/12/2019 at 12:16pm
02/12/2019 at 10:43am
27/11/2019 at 8:22pm
27/11/2019 at 10:46am
25/11/2019 at 10:12am
22/11/2019 at 12:58pm
22/11/2019 at 11:41am
22/11/2019 at 10:45am
21/11/2019 at 4:52pm
21/11/2019 at 10:33am
21/11/2019 at 10:31am
20/11/2019 at 7:06pm
"Part of Horne Family Pledge."
17/11/2019 at 6:02am
Followers 5
Followers of Puro New Zealand Limited - Wholesale
Puro New Zealand Limited - Wholesale
Puro's equity crowdfunding and wholesale campaigns are now fully subscribed. To be on the waiting list and be kept in the loop on possible future capital raising, please register your interest by clicking here.
The information below relates to Puro's Wholesale campaign - please refer to IM for explainer, and in footer of this campaign page for definition of wholesale investor.
Puro is setting out to become New Zealand’s best cultivator of medical cannabis and hemp.
We have secured two premium growing sites in sunny Marlborough and have formed a world-class team of experts to drive us forward.
We are the first medical cannabis company in New Zealand to have an approved cannabis licence prior to conducting a PledgeMe crowdfunding campaign, and already have purchase agreements with seven pharmaceutical manufacturers and wholesalers.
With land secured, a licence in place and letters of intent signed with large buyers, there’s only one thing we need to get growing: You.
We invite you to join us on our journey now. An investment with us positions you for considerable growth in this exciting industry. With Puro, you’ll be at the forefront of pioneering new medicine.
Offer at a glance
Puro is undertaking an equity crowdfunding campaign to raise $2million from New Zealand residents. Concurrently, a wholesale campaign is also being undertaken to raise a further $2million from wholesale investors. Shares are priced at $1 each for both offers.
- The crowdfunding offer equates to 7.29% of the investor shares available. The minimum investment amount is $500.
- The wholesale offer is separate to the crowdfunding offer and is also for a 7.29% stake in Puro New Zealand Limited. The minimum investment amount is $50,000.
Our land
Puro has secured two premium growing sites in Marlborough. These sites provide us with the capacity to be the largest cultivator in New Zealand.
We handpicked our sites due to their high sunshine hours, intense UV ratings, and its clean environment. Couple that together with rich soils and a unique micro-climate give us the perfect locations.
Marlborough already produces some of the world’s premium food and wine, our product will be equally world-class.
Destined to become Puro's research headquarters, this 9-hectare property is currently part of an existing cherry orchard nestled in a quiet area of the Waihopai Valley in Marlborough. We plan to build high-security greenhouses for growing medical cannabis and establish research facilities in existing buildings.
This will enable us to produce premium indoor cannabis — a product that we anticipate will be among the best in the world.
We expect to grow up to 200 plants in our secure facility at Waihopai, and undertake research on all strains and cultivars including high-THC genetics
- Optional expansion: 33.5 ha
- Site crop: Premium medicinal cannabis
- Facilities: 400m2 research facility with three vegetative growing room and commerical greenhouses covering 10,000-30,000m2
- Potential output: 20,000—60,000 kg dried flower PA
- Lease duration: 21 years plus right to purchase
Our research has shown this coastal site is high in sunshine hours and receives a gentle salt spray from the ocean, which our botanists say will ward off pests naturally, and improve plant health. This natural self-defence has another benefit: it will also increase the cannabinoid profile of our plants. This should translate into higher yields, which makes for greater returns for our investors.
- Optional expansion: 80 ha
- Site crop: Low THC hemp
- Potential output: 40,000—160,000 kg dried hemp flower PA
- Lease duration: 20 years
Licenced to grow
Under current New Zealand law, growing, extracting, and manufacturing cannabis for therapeutic use can only be undertaken for scientific research. This will change soon with the introduction of the Medicinal Cannabis Scheme, which we expect will be operational in March 2020.
Puro is the first medical cannabis company in New Zealand with an approved licence to undertake scientific cannabis research prior to commencing a crowdfunding campaign.
We currently have our licence pending with the Ministry of Health to cultivate low-THC hemp at Kekerengu, and we anticipate this to be granted in advance of our planned planting in December 2019.
A rapidly growing market
The global medical cannabis market is big and getting bigger. With governments around the world increasing access for those with chronic health conditions, it’s one of the fastest-growing industries in the world.
While it is clear that the global medical cannabis market is increasing, estimates of the exact size of the international medical cannabis market vary greatly.
For example:
- “The global medical cannabis market size was estimated to reach a value of US$13.4billion in 2018. The market is further expected to reach a value of US$44.4billion by 2024.”
- “Medical Marijuana Market size is set to exceed US$55.0 billion by 2024.”
- The global legal marijuana market is expected to reach USD$146.4 billion by the end of 2025.”
- “Barclays suggests that the global cannabis market could be worth USD$272 billion by 2028.”
Closer to home, research from The AgriBusiness Group into the New Zealand market concluded that if 1% of those who could benefit from medical cannabis in New Zealand obtained a prescription, the market could be worth $379 million each year.
Valuation, growth plans and revenue
Given the rapidly growing nature of the medical cannabis market, it is not surprising there is potential for significant investor returns.
Puro has been conservatively valued at $25million, using an EBITDA multiplier of just 2 and an implied revenue multiplier of only 1.1. If the average Canadian multipliers (revenue multiplier of 4.8 and EBITDA multiplier of 15.9) were used to value Puro it would result in valuations between $98.9 million - $199.4 million, demonstrating the potential significant upside for investors.
Based on conservative profitability assumptions, we anticipate PledgeMe investors can expect an after-tax return on investment of 34% at the end of our first full year of production (at March 2021), and 66% by March 2022.
Use of Capital
Funds raised through our PledgeMe campaign will be primarily used to:
- Build our research facility
- Invest in security
- Purchase extraction equipment
- Greenhouse development
- Expand further into international market
- Adminstration and capital raising costs
Capitalisation Table
Shareholding details for pre- and post-offer shall be as follows:
About our Team
Puro was setup in 2018 by passionate South Islanders and since then we have formed a formidable team with considerable business, finance and cultivation expertise.
Tim Aldridge (managing director): Tim was born and raised in Blenheim and worked in business consultancy before setting up Party Warehouse in 2001, which he grew to become the South Island’s largest marquee and event company. HireKING was Tim’s next success, and in 2017 it was named as one of the top 50 fastest growing companies in New Zealand. Tim was also a founding director of Team Event, which runs some of the largest annual events in the South Island including the Great Kiwi Beer Festival and Electric Avenue. |
||
Sank Macfarlane (Director): A 5th generation Marlbourian, Sank’s family have farmed the Winterhome Farm, at Kekerengu on the Kaikoura Coast, for 130 years. Prior to his current role, Sank enjoyed a 16-year career in international banking, which provided him with a deep understanding of global financial markets. Sank is also a board member of the Marlborough Kaikoura Trail Trust which is funding, designing and building a cycleway from Picton to Christchurch.
|
||
Wayne Bailey (director): With more than 40 years’ experience as a chartered accountant, Wayne is the Executive Director of financial consultancy Taurus Group. He is a specialist in corporate restructuring, financial and succession planning as well as developing, growing and advising businesses. Wayne is an astute businessman, a clear thinker and a smart communicator. |
||
Tom Forrest (cultivation director, agronomist): An Australian 2018 Churchill Fellow, author of ‘A Global Analysis of Cannabis Cultivation’, and a leading consultant in the global cannabis space, Tom is leading Puro’s agronomic team to produce quality high-yielding cannabis and hemp at scale. Tom, who is co-founder of Indicated Technology, has also been instrumental in connecting Puro with pharmaceutical manufacturers and international buyers. |
Puro is surrounded by a talented team with proven track records across a range of sectors – from start-ups, investment and investor relations to governance, finance, horticulture and farming. Add to this the expertise of our internationally respected botany, agronomy and research partners, and you’ll see Puro is perfectly positioned for success.
Puro has partnered with the leading experts and brightest lights in the medical cannabis industry.
By aligning ourselves with the best in the world, we aim to generate the highest yields whilst reducing our costs of production. Ultimately, this will help us to increase profits and provide optimum returns for our shareholders.
Puro's achievements and what lies ahead
Our financial modelling will to take advantage of lucrative short-term pricing, which will put Puro into a cashflow positive position once our commercial facilities are built and operational (commencing mid-2020). This cashflow could be used to pay a dividend to all shareholders including, of course, our PledgeMe investors, although our anticipation is to use all surplus cash to expand and bolster our commercial facilities in order to scale quickly and enter global markets. We believe that reinvesting any dividends will leverage our growth and strengthen the company.
Any dividend payments made will be distributed equitably to shareholders, including, of course, our PledgeMe and Wholesale investors. Likewise, any increase in company value as we move into commercial cultivation and expand globally will be reflected in the value of your shareholding.
The directors have not outlined any exit strategy and nor can we make any promises around our intentions or possible directions in this space. Saying that, if Puro can achieve its plans of producing the “Sauvignon Blanc of Cannabis” becoming a NZ’s best and potentially biggest cultivator, with a global brand recognised for its quality, trust and consistency, our company could possibly become appealing to a larger buyer. This may potentially include another company wanting to enter the market or to leverage our branding and success into their existing operations and distribution channels.
The directors are unlikely to list Puro on the NZ or Australian stock exchanges (NZX or ASX).
Risks and mitigation
Note from PledgeMe
We have completed a Veda check on the company and their Director, as well as a Google check. There were no adverse findings.
The Directors's have all passed Police vetting and responsible person's tests as part of the cannabis research license approval.
Definition of wholesale investor
A wholesale investor can be defined as people who meets any one of these 5 criterion:
- are an investment business, in that their principal business involves investing in financial products, acting as an underwriter, providing financial advisory services, providing broking services or trading financial products;
- have, during the previous two year period, owned a portfolio of, or carried out transactions to acquire financial products of a value of at least $1 million;
- have, in the previous two years, materially participated in the investment decisions made by an investment business;
- have, or any entities controlled by them, have, as at the last day of the two most recently completed financial years, net assets or total consolidated turnover exceeding $5 million;
- are "eligible investors", and have certified that they have previous experience in acquiring or disposing of financial products that allows them to assess:
- the merits of the transaction;
- their own information needs in relation to the transaction;
- the adequacy of the information provided, that they understand the consequences of so certifying, and the grounds for this certification; or
- an authorised financial adviser, a chartered accountant, or a lawyer signs a written confirmation of the certification.
We did it - $4million raised!
06/12/2019 at 11:09 AM
THANKS!
In four weeks we’ve gone from being an unknown start-up to raising $4 million on PledgeMe - the highest ever equity crowdfunding campaign in New Zealand and Australia.
And today we are planting!
And we have you to thank for it – thank you for believing in us.
We’ve raised $2million in our equity campaign and $2million in our wholesale campaign, and we will use the money to build medical cannabis growing facilities and buy state-of-the-art processing equipment.
Nearly 750 people have backed us and there’s already 135 people on our waiting list for future investment opportunities (people can sign up here https://www.puro.co.nz/invest/).
Once again thank you so much for your support. It’s been incredibly humbling.
We have the land, we have the team, we have the licences and the buyers. And now, thanks to you, we have the capital we need to get growing.
Let’s do this!
The Puro team
Tim, Sank, Wayne and Tom
You need to pledge to see this update.
Offer Details
Current Valuation | 23,417,862 |
Raise Minimum | 0 |
Raise Maximum | 2,000,000 |
Share Price | 1.00 |
Minimum Pledge | 50,000.00 |
Maximum Shares Offered | 2,000,000 |
Explanation of valuation:
An independent valuation of Puro New Zealand Ltd by Taurus Group has valued the company shares at $23,417,862. This has been determined by using a forecasted equity value analysis using an EBITDA (Earnings Before Interest, Tax, Depreciation & Amortisation) multiple of 2 for the 2021 year and accumulated losses from the initial 2020 year.
Another common method to value a company, particularly for crowdfunding in New Zealand, is to use a revenue multiplier (4-5 times revenue is often adopted). International benchmark data for the cannabis industry has determined multiples of 0.9 to 10.5, with an average of 4.8.
Applying a conservative multiplier of 1-2 times to forecast 2021 revenue would result in a valuation of Puro shares of between $20.6million – $41.2million. If the average multiple of 4.8 was applied, the valuation of Puro would lift to $98.9million, demonstrating the potential upside to investors.
The Directors have valued the total shares pre-raise at $23,417,862 in accordance with our independent valuation. Post-raise, if both our crowdfunding and wholesale offers are fully subscribed the valuation for Puro will be $29,347,845. We believe this provides excellent potential returns for our shareholders with forecasted return on investment on the above valuation being 34% (after tax) for the first full year trading 2021.
Financial Summary
Prev Year | Current Year | Est. FY 2025 | Est. FY 2026 | |
---|---|---|---|---|
Revenue | NZ $0 | NZ $172,080 | NZ $20,596,560 | NZ $37,585,200 |
Operating Expenses | NZ $0 | NZ $1,713,672 | NZ $6,857,624 | NZ $11,149,009 |
EBITDA | NZ $0 | -NZ $1,596,592 | NZ $13,305,523 | NZ $25,363,818 |
Net Profit | NZ $0 | -NZ $1,703,354 | NZ $12,267,735 | NZ $24,047,187 |
Company Details
Company Name: Puro New Zealand Ltd
Company Number: 7148653
Company Documents
Director Details
Name | Role | Profile URL | Invested? |
---|---|---|---|
Timothy James ALDRIDGE | Managing Director | https://www.linkedin.com/in/tim-aldridge-080586179/ | ✔ |
Sandford Samuel MACFARLANE | Director | https://www.linkedin.com/in/sank-macfarlane-14747674/ | ✔ |
Errol Wayne BAILEY | Director | https://www.linkedin.com/in/wayne-bailey-15994710/ | ✗ |
Hi Tim, you have mentioned future capital raising,will this be done in a pledge me setting and the shares you will be offering come from the current share holders stakes or do you intend to down water down the investors share as well who have purchased shares in this pledge me campaign as well ? cheers
Posted on 29-11-2019 by seanHi sean. The exact details of any future capital raising have not yet been determined. Whatever decisions are made will be informed by what is in the best interests of our shareholders.
Answered on 03-12-2019 by Puro New Zealand
Followers of Puro New Zealand Limited - Wholesale
04/12/2019 at 11:01am
"Faith, Trust and Angle Dust"
04/12/2019 at 5:24am
03/12/2019 at 11:16am
03/12/2019 at 10:18am
02/12/2019 at 12:16pm
02/12/2019 at 10:43am
27/11/2019 at 8:22pm
27/11/2019 at 10:46am
25/11/2019 at 10:12am
22/11/2019 at 12:58pm
22/11/2019 at 11:41am
22/11/2019 at 10:45am
21/11/2019 at 4:52pm
21/11/2019 at 10:33am
21/11/2019 at 10:31am
20/11/2019 at 7:06pm
"Part of Horne Family Pledge."